These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
101 related articles for article (PubMed ID: 12702094)
1. High-density lipoprotein cholesterol in patients with psoriatic arthritis. Skoczyñska AH; Turczyn B; Barancewicz-Losek M; Martynowicz H J Eur Acad Dermatol Venereol; 2003 May; 17(3):362-3. PubMed ID: 12702094 [No Abstract] [Full Text] [Related]
2. Intravenous anti TNF-alpha antibody therapy leads to elevated triglyceride and reduced HDL-cholesterol levels in patients with rheumatoid and psoriatic arthritis. Cauza E; Cauza K; Hanusch-Enserer U; Etemad M; Dunky A; Kostner K Wien Klin Wochenschr; 2002 Dec; 114(23-24):1004-7. PubMed ID: 12635469 [TBL] [Abstract][Full Text] [Related]
3. Modest but sustained increase of serum high density lipoprotein cholesterol levels in patients with inflammatory arthritides treated with infliximab. Spanakis E; Sidiropoulos P; Papadakis J; Ganotakis E; Katsikas G; Karvounaris S; Bizaki A; Kritikos H; Boumpas DT J Rheumatol; 2006 Dec; 33(12):2440-6. PubMed ID: 17014005 [TBL] [Abstract][Full Text] [Related]
4. Association of 25-hydroxyvitamin D serum levels and metabolic parameters in psoriatic patients with and without arthritis. Orgaz-Molina J; Magro-Checa C; Rosales-Alexander JL; Arrabal-Polo MA; Buendía-Eisman A; Raya-Alvarez E; Arias-Santiago S J Am Acad Dermatol; 2013 Dec; 69(6):938-46. PubMed ID: 24094453 [TBL] [Abstract][Full Text] [Related]
5. Active peripheral inflammation is associated with pro-atherogenic lipid profile in psoriatic arthritis. Shrestha A; Bahce-Altuntas A; Mowrey W; Broder A Semin Arthritis Rheum; 2016 Dec; 46(3):286-290. PubMed ID: 27373499 [TBL] [Abstract][Full Text] [Related]
6. Cardiovascular risk profile of patients with psoriatic arthritis compared to controls--the role of inflammation. Tam LS; Tomlinson B; Chu TT; Li M; Leung YY; Kwok LW; Li TK; Yu T; Zhu YE; Wong KC; Kun EW; Li EK Rheumatology (Oxford); 2008 May; 47(5):718-23. PubMed ID: 18400833 [TBL] [Abstract][Full Text] [Related]
7. Psoriasis vulgaris with or without arthritis and independent of disease severity or duration is a risk factor for hypercholesterolemia. Santos-Juanes J; Coto-Segura P; Fernández-Vega I; Armesto S; Martínez-Camblor P Dermatology; 2015; 230(2):170-6. PubMed ID: 25634083 [TBL] [Abstract][Full Text] [Related]
8. Dyslipoproteinemia in the course of active rheumatoid arthritis. Lazarevic MB; Vitic J; Mladenovic V; Myones BL; Skosey JL; Swedler WI Semin Arthritis Rheum; 1992 Dec; 22(3):172-8. PubMed ID: 1295090 [TBL] [Abstract][Full Text] [Related]
9. Total cholesterol, lipoprotein, and triglyceride levels in tumor necrosis factor inhibitor-treated patients with psoriasis, psoriatic arthritis, or rheumatoid arthritis. Wu JJ; Rowan CG; Bebchuk JD; Anthony MS Int J Dermatol; 2015 Oct; 54(10):e442-5. PubMed ID: 26234307 [No Abstract] [Full Text] [Related]
10. Lipoproteins and their subfractions in psoriatic arthritis: identification of an atherogenic profile with active joint disease. Jones SM; Harris CP; Lloyd J; Stirling CA; Reckless JP; McHugh NJ Ann Rheum Dis; 2000 Nov; 59(11):904-9. PubMed ID: 11053070 [TBL] [Abstract][Full Text] [Related]
11. Apolipoprotein A-I and cholesterol in synovial fluid of patients with rheumatoid arthritis, psoriatic arthritis and osteoarthritis. Oliviero F; Sfriso P; Baldo G; Dayer JM; Giunco S; Scanu A; Bernardi D; Ramonda R; Plebani M; Punzi L Clin Exp Rheumatol; 2009; 27(1):79-83. PubMed ID: 19327233 [TBL] [Abstract][Full Text] [Related]
12. From the Editor: Cytokines and HDL cholesterol. Foreword. Brown WV J Clin Lipidol; 2015; 9(1):1. PubMed ID: 25670353 [No Abstract] [Full Text] [Related]
13. Correlation of High-Density Lipoprotein-Associated Paraoxonase 1 Activity With Systemic Inflammation, Disease Activity, and Cardiovascular Risk Factors in Psoriatic Disease. Husni ME; Wilson Tang WH; Lucke M; Chandrasekharan UM; Brennan DM; Hazen SL Arthritis Rheumatol; 2018 Aug; 70(8):1240-1250. PubMed ID: 29569857 [TBL] [Abstract][Full Text] [Related]
14. Vitamin D3 levels and bone mineral density in patients with psoriasis and/or psoriatic arthritis. Kincse G; Bhattoa PH; Herédi E; Varga J; Szegedi A; Kéri J; Gaál J J Dermatol; 2015 Jul; 42(7):679-84. PubMed ID: 25959376 [TBL] [Abstract][Full Text] [Related]
15. Vascular endothelial growth factor in patients with psoriatic arthritis. Fink AM; Cauza E; Hassfeld W; Dunky A; Bayer PM; Jurecka W; Steiner A Clin Exp Rheumatol; 2007; 25(2):305-8. PubMed ID: 17543159 [TBL] [Abstract][Full Text] [Related]
16. Cytidine deaminase activity, C reactive protein, histidine, and erythrocyte sedimentation rate as measures of disease activity in psoriatic arthritis. Helliwell PS; Marchesoni A; Peters M; Platt R; Wright V Ann Rheum Dis; 1991 Jun; 50(6):362-5. PubMed ID: 2059079 [TBL] [Abstract][Full Text] [Related]
17. A comparative study of serum and synovial fluid lipoprotein levels in patients with various arthritides. Oliviero F; Lo Nigro A; Bernardi D; Giunco S; Baldo G; Scanu A; Sfriso P; Ramonda R; Plebani M; Punzi L Clin Chim Acta; 2012 Jan; 413(1-2):303-7. PubMed ID: 22037510 [TBL] [Abstract][Full Text] [Related]
18. The Effects of 5-year Etanercept Therapy on Cardiovascular Risk Factors in Patients with Psoriatic Arthritis. Agca R; Heslinga M; Kneepkens EL; van Dongen C; Nurmohamed MT J Rheumatol; 2017 Sep; 44(9):1362-1368. PubMed ID: 28572461 [TBL] [Abstract][Full Text] [Related]
19. Association between small dense LDL and sub-clinical atherosclerosis in patients with psoriatic arthritis. Gentile M; Peluso R; Di Minno MND; Costa L; Caso F; de Simone B; Iannuzzo G; Scarpa R; Rubba P Clin Rheumatol; 2016 Aug; 35(8):2023-2029. PubMed ID: 27411815 [TBL] [Abstract][Full Text] [Related]
20. [Cardiovascular risk in psoriatic arthritis]. Badokin VV; Ianysheva AV; Aleksandrova EN; Mach ES; Popkova TV Ter Arkh; 2009; 81(6):41-7. PubMed ID: 19663192 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]